Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 22, 2022--
The "Global IoT Healthcare Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The global IoT healthcare market is anticipated to grow at a CAGR of around 16.8% during the forecast period. IoT enables the healthcare professional to connect with the patients more proactively.
Companies Mentioned
The data collected through IoT devices support the physicians to devices on the best treatment option for the patient. Certain benefits of IoT healthcare include cost reduction, productivity and more efficiency, enhanced customer experience and mobility and agility.
The increased adoption of health and fitness due to COVID-19 will be increasing the use of real-time health monitoring increasing the IoT healthcare market. Rise of usage of connected technology devices to manage operational as well as clinical tasks further drives the growth of the market. Large adoption of electronic health records (EHR) has been the major factor driving the market growth.
Additionally, rising investments from major healthcare IT companies and increasing healthcare spending acts as some major motivators for the market. Moreover, the rising geriatric population creates demand for remote monitoring and EHR applications.
High costs of IoT healthcare along with lack of skilled professionals towards this technology act as major restraints for the market growth. The reason behind the high cost is the requirement of the installation of software, hardware, training fees, networking infrastructure, &IT support. However, ongoing improvements in healthcare expenditure and rising demand for IoT healthcare in developing countries are expected to drive the market growth in developing countries in the upcoming years.
The Report Covers
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Microarray Market by Type
5.1.1. DNA Microarrays
5.1.2. Protein Microarray
5.1.3. Peptide Microarray
5.1.4. Tissue Microarray
5.1.5. Others (Cellular Microarray)
5.2. Global Microarray Market by Application
5.2.1. Diagnosis and Prognosis
5.2.2. Pharmacogenomics and Theragnostic
5.2.3. Drug Discovery
5.2.4. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/nus9fn
View source version on businesswire.com:https://www.businesswire.com/news/home/20220922005617/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY HEALTH IOT (INTERNET OF THINGS)
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/22/2022 09:03 AM/DISC: 09/22/2022 09:03 AM
http://www.businesswire.com/news/home/20220922005617/en